This document outlines an exclusive GP-led secondary deal for SOF IV, expected to close in June 2018. It involves a mid-market buyout strategy focusing on Europe/UK, with investments in business services and healthcare services. The transaction includes four companies, with key value drivers in the UK premium distribution and medical/cosmetics clinic sectors. The investment rationale highlights growth opportunities and cost efficiency initiatives.
documents/vol00010-efta01355299-pdf.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"2018-06","document_type":"tabular","key_locations":["Europe","UK","Italy"],"document_subtype":"Investment Summary","key_organizations":["Glendower Capital","Annandale Capital"]}